Researchers have found that tapping into the body's own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of tumor-infiltrating ...

Portuguese researchers have discovered that a type of white blood cell that can identify and kill tumour cells could be the key to a new immunotherapy against colorectal cancer, the most common type ...

Scientists have discovered a promising new way to slow down aging at the cellular level using a special type of whey protein ...

A phase 1 clinical trial has found one such immunotherapy to be safe for patients with several types of B-cell lymphoma, a type of blood cancer. Larger studies are needed to assess efficacy, but ...

Immunotherapy Research: Independently design, plan, and execute experiments involving CAR-T cell engineering, optimization, and evaluation using advanced cellular, molecular, and immunological ...

A new form of tumor infiltrating lymphocyte (TIL) therapy, a form of personalized cancer immunotherapy, dramatically improved the treatment's effectiveness in patients with metastatic gastrointestinal ...

The Food and Drug Administration (FDA) has approved Opdivo ® (nivolumab) in combination with Yervoy ® (ipilimumab) for the first-line treatment of adult patients with unresectable or metastatic ...

CERo Therapeutics (CERO) announces the allowance of two patent applications submitted to the U.S. Patent and Trademark Office, USPTO, which ...

These observations may help us find novel ways to improve immunotherapy.” Unexpectedly, the jammed signal within cancer cells was coming from mitochondria, which has its own unique DNA. As cellular ...

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of ...

Researchers at Moffitt Cancer Center have found that tapping into the body’s own immune system and activating a type of immune cell known as B cells, could be the key to boosting the effectiveness of ...

The approach also shaved up to one week off the manufacturing time, potentially getting the cellular immunotherapy to patients sooner. Finally, the enhanced cells were more "stem-like," a trait ...